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Abstract
Objectives
To investigate the effects of traditional antiepileptic drugs (AEDs) 
versus newer AEDs on the thyroid hormone profile of children with 
epilepsy. 
Materials & Methods
A total of 80 children with epilepsy were included in this study and 
were divided into two groups. Group 1 included 40 children with 
epilepsy on traditional AEDs, and group 2 included 40 children with 
epilepsy on newer AEDs. Forty healthy children were also included 
as the control group (group 3). We analyzed the serum levels of free 
triiodothyronine (FT3), free thyroxine (FT4), and thyroid stimulating 
hormone (TSH).
Results
In epileptic children treated with traditional drugs, there was a 
significant reduction in the serum level of FT4 and a significant 
increase in TSH concentration, compared to the control group 
(P<0.001). Conversely, epileptic children treated with newer AEDs 
showed no significant changes in the serum concentrations of FT3, 
FT4, and TSH, compared to the control group. 
Conclusion
Traditional AEDs have more significant effects on thyroid hormone 
profile, compared to newer AEDs.
Keywords: Antiepileptic drugs, Thyroid function, Subclinical 
hypothyroidism, Children.
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Introduction
Epilepsy is a common neurological disorder, 
characterized by a disturbance in the electrical 
activity of the brain due to different factors. It 
includes many types of seizures with variable 
severity, seizure semiology, etiology, consequences, 
and management (1). It is a chronic disorder, which 
requires long-term therapy with antiepileptic drugs 
(AEDs). However, in some patients, seizures are 
resistant to AEDs despite appropriate treatment, 
and lifelong therapy is usually indicated (2). 
Prolonged use of AEDs is associated with the 
increased risk of adverse events, such as drug 
interactions, cognitive dysfunction, idiosyncrasy, 
behavioral changes, and metabolic or endocrinal 
disturbances (2,3), particularly thyroid gland 
dysfunction.4 Thyroid hormones play an 
important role in the regulation of metabolism in 
many tissues. Therefore, disturbance of thyroid 
hormones has major implications for the growth 
and development of children (5). 
The impact of AEDs on thyroid function is well-
known in adults.6 However, disturbance of thyroid 
function in children receiving AEDs is a matter of 
controversy, and there is limited information in this 
context (4,7). Among drug therapies for epileptic 
children, most epileptologists preferred traditional 
AEDs, such as valproate, carbamazepine, and 
phenobarbital in the past. However, recently, 
major attention has been paid to newer drugs, such 
as levetiracetam, topiramate, oxcarbazepine, and 
lamotrigine. Newer AEDs are used as monotherapy, 
as well as add-on therapy for children with epilepsy 
(1). Previous studies have reported the effects of 
traditional AEDs on thyroid hormones in children. 
However, there is limited evidence regarding the 
effects of newer AEDs (8).
Several studies reported no change in the level of 
thyroid hormones among children with epilepsy 
receiving AEDs (9,10), while others indicated 
significant alterations in the level of thyroid 
hormones (11,12). Administration of AEDs can 
result in subclinical hypothyroidism, which is 
defined as the elevation of thyroid stimulating 
hormone (TSH) level above the upper limit of 
the age-specific reference range, while the serum 
level of free thyroxine (FT4) is within its reference 
range. 
Subclinical hypothyroidism appears to be a benign 
condition with a low risk of conversion into overt 
hypothyroidism. This condition has no adverse 
effects on neuropsychological functions (13-15) 
.Changes in thyroid function can be attributed to 
the administration of AEDs, especially traditional 
AEDs. Therefore, in this study, we aimed to 
investigate the effects of traditional AEDs versus 
newer AEDs on the thyroid hormone profile of 
children with epilepsy.
Materials & Methods
This cross-sectional study was conducted on 80 
children with epilepsy, including 48 males and 32 
females. The participants’ age ranged from three 
months to 15 years. All patients were recruited 
from the pediatric neurology outpatient clinic 
of Al-Hada and Taif military hospitals in Saudi 
Arabia and had received AED therapy for more 
than six months with good compliance. The 
patients were divided into two groups: 40 children 
with epilepsy on traditional AEDs including 
valproate, carbamazepine, and phenobarbital 
(group 1); and 40 children with epilepsy on newer 
AEDs, including levetiracetam, oxcarbazepine, 
and topiramate (group 2). In addition, 40 age- and 
sex-matched healthy children were recruited as the 
control group (group 3). 
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This study was conducted during February 
2016 and August 2016 after obtaining informed 
consents from the participants. Ethical approval 
was also obtained for the study. The study protocol 
conformed to the ethical guidelines of 1964 
Declaration of Helsinki and its later amendments. 
The exclusion criteria were as follows: 1) presence 
of an underlying etiology or drug-resistant 
seizures; 2) poor compliance; 3) polytherapy with 
more than one AED; 4) body mass index above 
the 95th percentile for age and gender; 5) thyroxine 
replacement therapy and use of anti-thyroid drugs; 
6) endocrinal, metabolic, or chronic medical 
disorders; and 7) symptoms suggestive of thyroid 
gland disorder.
Detailed history-taking, including demographic 
data, seizure type, epileptic syndrome, seizure 
etiology, onset age of epilepsy, selected AEDs, dosage 
of antiepileptic drugs, electroencephalographic 
(EEG) changes, and duration of AED therapy, was 
performed. Also, careful examination of thyroid 
glands for the presence of goiter was carried out.
Analysis of thyroid function 
A 5-mL venous blood sample was taken from 
each participant while taking aseptic precautions. 
Blood samples were collected between 8 a.m. 
and 10 a.m. after overnight fasting. The samples 
were then centrifuged to separate the serum. The 
serum was analyzed using a chemiluminescence 
autoanalyzer for proper assay of thyroid hormone 
profile, including free triiodothyronine (FT3), 
free thyroxine (FT4), and TSH concentrations. 
Commercial enzymatic methods were also used for 
hormonal analyses (Immulite, Siemens) (16).
The thyroid hormone profile was interpreted 
according to age-specific reference ranges (−2, 
−1, 0, 1, and 2 SDS) for thyroid hormones in 
children.17 The serum level of valproic acid was 
measured via chemiluminescent immunoassay 
in an Immulite 2000 system (Siemens Medical 
Solutions, USA). The serum level of carbamazepine 
was also measured using florescence polarization 
immunoassay in an INTEGRA 400 system (Roche 
Diagnostics, USA). Finally, the serum level of 
phenobarbital was measured using an enzyme 
immunoassay in an Emit® 2000 system (Siemens 
Healthcare Diagnostics, USA) (18).
Statistical analysis
Data and variables were analyzed using SPSS 
version 10.0 (Chicago, IL, USA). Values are 
expressed as mean±standard deviation (SD). One-
way analysis of variance (ANOVA), followed 
by post hoc Dunnett’s test, was used to evaluate 
significant differences between the groups. 
Qualitative data are also presented as number and 
percentage. To evaluate significant differences 
between the groups, Chi-square test was performed. 
P-value less than 0.05 was considered statistically 
significant.
Results
Eighty epileptic children were enrolled in this study, 
including 48 males and 32 females. The participants’ 
age ranged from three months to 15 years. Group 
1 included 40 epileptic children on traditional 
AEDs, including valproate, carbamazepine, and 
phenobarbital. The age of patients in this group 
ranged from three months to 12 years, with the 
mean age of 6.08±3.64 years. Group 2 included 
40 epileptic children on newer AEDs, including 
levetiracetam, topiramate, and oxcarbazepine. The 
patients’ age in this group ranged from eight months 
to 15 years, with the mean age of 7.12±4.03 years. 
Also, group 3, which served as the control group, 
consisted of 40 age- and sex-matched healthy 
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children. The mean age of the participants in this 
group was 6.58±3.56 years. 
Valproate was the most commonly used traditional 
AED, whereas levetiracetam was the most 
common AED among newer agents. Duration of 
drug therapy was 1.65±0.84 years in group 1 and 
2.01±0.92 years in group 2. Among 40 epileptic 
children in group 1, 19 (47.5%) received valproate, 
14 (35%) received carbamazepine, and 7 (17.5%) 
received phenobarbital. On the other hand, among 
40 epileptic children in group 2, 21 (52.5%) 
received levetiracetam, 15 (37.5%) received 
topiramate, and 4 (10%) received oxcarbazepine. 
All AEDs were administered at appropriate doses 
with strict compliance.
EEG changes mostly included focal activity in 
form of sharp or spike waves and generalized 
spike-and-wave activity in both groups, while 
the background activity was normal. Serum 
concentrations of AEDs were within therapeutic 
ranges in all patients. Administration of different 
AEDs in patients is shown in Figure 1. 
With regard to the serum levels of FT3, FT4, and 
TSH, epileptic children treated with traditional 
drugs (group 1) showed a significant decrease in 
FT4 (0.76±0.13) and a significant increase in TSH 
concentration (3.61±1.36), compared to the control 
group (group 3) (FT4: 0.98±0.07; TSH: 2.15±0.81) 
(P<0.001). However, epileptic children treated 
with newer AEDs showed no significant changes 
in the serum concentrations of FT3, FT4, and TSH, 
compared to the control group (P=0.35, 0.24, and 
0.61, respectively). Also, the results showed a 
significant difference between group 1 and group 2 
in terms of serum concentrations of FT4 and TSH 
(P<0.01) (Table 1). Eight (20%) patients from 
group 1 (FT4: 0.96±0.08; TSH: 3.54±1.44) and 
two (5%) patients from group 2 (FT4: 0.94±0.08; 
TSH: 3.46±1.41) were diagnosed with subclinical 
hypothyroidism. Nevertheless, none of the controls 
showed evidence of subclinical hypothyroidism.
With regard to the prevalence of subclinical 
hypothyroidism in the studied groups, there was 
a significant difference between epileptic children 
treated with traditional drugs (group 1) and the 
control group (group 3) (P<0.01). However, the 
prevalence of subclinical hypothyroidism was not 
significantly different between epileptic children 
treated with newer drugs (group 2) and the control 
group (group 3) (P=0.19). Meanwhile, in epileptic 
children treated with traditional drugs (group 1), 
a significantly higher prevalence of subclinical 
hypothyroidism was reported, compared to 
epileptic children treated with newer drugs (group 
2) (P<0.05) (Table 2).
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Table 1: Serum level of thyroid hormone among studied groups.
Serum level of 
thyroid hormone
Epileptic children treated with 
traditional AEDs
(Group1)


























Values are expressed as mean±SD for all variables. *: test the significance compared to control group(Group 3).The comparison was done by 
one-way ANOVA analysis followed by post hoc Dunnett’s test. Group 1and Group 2 were compared to Group 3.fT3: free triiodothyronine, fT4: 
free thyroxine, TSH: thyroid stimulating hormone.
Table 2: Prevalence of subclinical hypothyroidism among studied groups.
Epileptic children treated with 
traditional AEDs
(Group1)













Values are expressed as number and percent. *: test the significance compared to control (Group 3). The comparison was done by chi2 test .P: 
test the significance between Group 1and Group 2.
 
 











Figure 1: Percentage of antiepileptic drugs administered by the patients.
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Discussion
While previous studies assessing thyroid function 
in epileptic children suggest that levels of thyroid 
hormones are not directly related to epilepsy, some 
changes in thyroid function may be attributed to 
the administered AEDs (19). It is well-established 
that thyroid hormones play an important role in 
different physiological processes. Hypothyroidism 
may progress into a metabolic syndrome with the 
involvement of many systems (20,21). Therefore, 
level of thyroid hormone needs to be measured 
and investigated thoroughly for epileptic children 
under long-term therapy with AEDs. 
Thyroid dysfunction has been associated with the 
administration of different AEDs. In our study, 
we found a significant decrease in the serum level 
of fT4 and an increase in the serum level of TSH 
(P<0.001) in epileptic children receiving traditional 
AEDs, compared to the control group. However, 
the serum level of fT3 was not influenced by the 
administration of AEDs (P=0.38). T3 is derived 
from the transformation of T4 in peripheral tissues. 
Serum levels of T3 and FT3 remain normal even 
in severe cases of hypothyroidism and are less 
sensitive in the diagnosis of hypothyroidism (22). 
Therefore, there was no significant change in the 
serum level of FT3 in our study. Our results are 
consistent with a study by Yilmaz et al., which 
showed a reduction in the serum level of FT4 and an 
increase in the serum level of TSH with valproate, 
carbamazepine, and phenobarbital administration, 
but not levetiracetam (8). Yehia et al. found similar 
results in their study (23).
In our study, we reported subclinical hypothyroidism 
in 20% of epileptic children treated with traditional 
drugs and 5% of epileptic children treated with 
newer drugs. However, none of the participants in 
the control group showed evidence of subclinical 
hypothyroidism. We found that none of our patients 
developed overt symptoms of hypothyroidism, and 
all patients were clinically euthyroid. According to 
previous studies, subclinical hypothyroidism may 
develop in epileptic patients during treatment with 
AEDs (24, 25). However, no symptoms or signs 
of hypothyroidism were reported (24). These 
changes did not affect the development of puberty 
among children. In other words, the prevalence 
of clinically manifest thyroid disorders is rare. 
However, these results may indicate the increased 
risk of hypothyroidism among epileptic patients 
treated with AEDs (27). 
Our findings showed a significantly higher 
prevalence of subclinical hypothyroidism in 
epileptic children treated with traditional drugs 
(group 1), compared to group 2 and group 3 (P<0.05 
and P<0.01, respectively). In this regard, Yilmaz 
et al. and Sahu et al. reported a prevalence rate 
of 25% in epileptic children on valproate therapy 
(8,12). Subclinical hypothyroidism was detected 
in healthy control children with a prevalence 
of 0-7.7%. Generally, the association between 
epilepsy and altered thyroid function is not fully 
understood. Subclinical hypothyroidism has been 
reported in epileptic children before the onset of 
treatment; this may suggest that epilepsy plays a 
role in thyroid dysfunction (11, 12). 
Valproate, carbamazepine, and phenobarbital were 
the most commonly used traditional AEDs in 
our study. Previous studies showed a significant 
decrease in the serum level of FT4 and an increase 
in the serum level of TSH in patients treated with 
VPA; these changes were persistent throughout 
the study (8,11,28,29,30). In another study on 
adolescent girls with epilepsy, the group receiving 
valproate showed higher serum levels of TSH 
and lower serum levels of FT4, compared to 
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the untreated group, although the values were 
still within the normal range (9). Other studies 
found that TSH level increased in patients using 
valproate, while FT4 level remained unchanged 
(12,28,31,32). On the other hand, several studies 
found that both FT4 and TSH concentrations 
were unaffected in patients treated with valproate 
(10,32). 
Similarly, previous studies indicated a significant 
decrease in the serum level of FT4 and an increase 
in the serum level of TSH in patients treated with 
carbamazepine (8,3 1). Other studies demonstrated 
that the serum level of FT4 significantly reduced 
in patients receiving carbamazepine, whereas 
the serum level of TSH remained unchanged in 
children (5,28,31,33). In concordance with our 
results, Yilmaz et al. reported similar effects of 
phenobarbital on thyroid hormones (8). Epileptic 
children on phenobarbital were found to have 
significantly reduced serum levels of FT4, despite 
unchanged serum TSH, compared to the controls, 
as reported in other studies (8,34). Conversely, 
another study indicated no significant differences 
in the serum levels of FT4 and TSH between 
patients receiving phenobarbital and the control 
group (35). 
In line with our study, Adhimoolam and Arulmozhi 
reported similar findings by evaluating adult 
epileptic patients, who were administered traditional 
AEDs, including valproate, carbamazepine, and 
phenytoin (36). The controversial results regarding 
the effect of traditional AEDs on thyroid hormones 
in different studies can be partly attributed to 
differences in the study design and methods. 
The failure rate of the first AED prescription for 
patients with newly diagnosed epilepsy remains 
relatively high. This can be explained by the 
poor effectiveness and/or high frequency of side 
effects, which prompted further search for newer 
drugs. Generally, newer AEDs are better tolerated 
by patients, have few drug interactions, needless 
serum drug monitoring, and may have potential 
neuroprotective effects (36, 38). 
Introduction of new AEDs provides more options 
for the treatment of children with epilepsy. In an 
adult clinical trial, new AEDs, such as lamotrigine, 
oxcarbazepine, vigabatrin, levetiracetam, topiramate, 
zonisamide, felbamate, rufinamide, gabapentin, 
and perampanel, were approved as monotherapy 
and adjunctive therapy. Selection of a new AED for 
children with epilepsy depends on multiple factors, 
including age, etiology, cognitive development, 
and epileptic syndrome (39). Among our patients, 
levetiracetam, topiramate, and oxcarbazepine 
were commonly used. We observed no significant 
changes in the serum levels of FT3, FT4, and 
TSH (P=0.74, 0.58, and 0.83, respectively) by 
administration of these drugs in epileptic children, 
compared to the controls. Yilmaz et al. and 
Leskiewicz et al. reported similar effects of these 
newer drugs on thyroid hormones (8, 40). 
Evidence suggests that levetiracetam has 
fewer side effects than older AEDs. However, 
there is little evidence regarding the effects of 
levetiracetam on thyroid function. In a recent 
study, thyroid function was found to be unaffected 
in children receiving levetiracetam (35). 
Moreover, oxcarbazepine is structurally related 
to carbamazepine, but does not induce the same 
level of enzymatic activity. In adults, replacement 
of carbamazepine by oxcarbazepine can reverse 
the effects of carbamazepine on thyroid hormones 
(30). Previous studies found that the serum levels 
of fT4 significantly reduced in epileptic children 
receiving oxcarbazepine, whereas the serum level 
of TSH remained unchanged (8, 28, 31, 33). 
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So far, no evidence has been reported regarding 
the effect of topiramate on thyroid hormones in 
epileptic children. Meanwhile, Adhimoolam and 
Arulmozhi observed no significant changes in the 
thyroid hormone profile of adult epileptic patients, 
who were administered newer AEDs, including 
topiramate, levetiracetam, and clobazam (36).
Generally,  the mechanism of association between 
AEDs and thyroid hormones is still unclear. It was 
postulated that alterations in the serum levels of 
thyroid hormones are caused by AEDs through 
different mechanisms. 
Most circulating thyroid hormones are bound to 
plasma proteins, and FT3 and FT4 do not appear 
to interfere with thyroxin-binding globulin. In 
addition, AEDs can cause impairment in thyroid-
hormone homeostasis through changing their 
biosynthesis, secretion, metabolism, transport, 
and/or excretion (5). The most likely mechanism 
is attributed to the induction of hepatic enzyme, 
CYP450, by traditional AEDs (carbamazepine, 
phenobarbitone, and phenytoin), which is 
associated with the improved metabolism of 
thyroid hormones, resulting in the reduction of 
serum concentrations (31). Uridine 5’-diphospho-
glucuronosyltransferase (UGT) is responsible for 
glucuronidation and plays a definite role in the 
metabolism of thyroid hormones. Some studies 
reported high levels of UGT after exposure to 
AEDs (41). Another mechanism might be related 
to interference in the hypothalamic-pituitary-
thyroid axis, responsible for the regulation of 
thyroid hormone production (10). 
Carbamazepine can cause disturbance in thyroid 
hormones through inhibition of iodine uptake 
by the thyroid gland (42). We did not include a 
mechanistic approach in our study. However, based 
on our results, evaluation of thyroid hormone 
profile is recommended for epileptic children on 
long-term traditional AEDs, compared to newer 
drugs; therefore, complications due to thyroid 
dysfunction can be prevented. 
The main limitation of this study is the small 
sample size. Therefore, larger prospective studies 
are needed on patients to support our findings.
In conclusion, Traditional AEDs have significant 
effects on the thyroid hormone profile of epileptic 
children on long-term therapy, compared to 
newer AEDs. Although these effects were not 
accompanied by clinical hypothyroidism, screening 
of thyroid hormone profile is recommended. 
Further prospective studies are recommended on 
a larger sample of patients to confirm our results.
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